Bioproperties, Nanostructured System and Analytical and Bioanalytical Methods for Determination of Rapamycin: A

Karen Cristina Dos Santos1, Leidiana Rocha Dos Reis1, Camila Fernanda Rodero1

  • 1School of Pharmaceutical Sciences, São Paulo State University (UNESP), São Paulo, Brazil.

Insights

This review covers rapamycin, an mTOR inhibitor used in cancer therapy and as an immunosuppressant. It highlights nanomedicine approaches for drug delivery and analytical methods for rapamycin quantification.

Area of Science:

  • Pharmacology
  • Oncology
  • Nanomedicine
  • Analytical Chemistry

Background:

  • Rapamycin is a potent mTOR inhibitor impacting cell proliferation and immune response.
  • It is utilized in cancer treatment and investigated for enhanced delivery via nanomedicine.
  • Accurate quantification of rapamycin is crucial for therapeutic monitoring.

Purpose of the Study:

  • To review current research on rapamycin, focusing on nanomedicine applications.
  • To summarize analytical methodologies for rapamycin identification and quantification.
  • To consolidate information on rapamycin's role in cancer and immunosuppression.

Main Methods:

  • Literature review of scientific works on rapamycin.
  • Analysis of studies involving nanostructured drug delivery systems for rapamycin.
  • Examination of various analytical techniques including HPLC, mass spectrometry, and immunoassays.

Main Results:

  • Rapamycin's efficacy as an mTOR inhibitor and its use in cancer therapy are well-established.
  • Nanomedicine offers promising strategies to improve rapamycin's bioavailability and efficacy.
  • Advanced analytical techniques are essential for sensitive and accurate rapamycin detection.

Conclusions:

  • Rapamycin remains a significant therapeutic agent, particularly in oncology.
  • Nanotechnology advancements are crucial for optimizing rapamycin drug delivery.
  • Continued development of sensitive analytical methods is vital for rapamycin's clinical application.

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
86
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
102
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.3K